Skip to main content
Figure 7 | Journal of Experimental & Clinical Cancer Research

Figure 7

From: Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

Figure 7

Tumor cell sensitivity to standard drugs at their maximum concentrations used ex vivo. These concentrations were: 5-FU and irinotecan 1000 μM; oxaliplatin and mitomycin C 100 μM. Cell survival is expressed as survival index (SI %) in tumor samples from colorectal and gastric cancer. Results are presented as mean values + SE. Number of samples investigated was 15 or 16 for gastric cancer and 51 or 52 for colorectal cancer.

Back to article page